Mingeot-Leclercq M P, Piret J, Brasseur R, Tulkens P M
Labortoire de Chimie Physiologique, Université Catholique de Louvain, Bruxelles, Belgium.
Biochem Pharmacol. 1990 Aug 1;40(3):489-97. doi: 10.1016/0006-2952(90)90547-x.
Aminoglycoside antibiotics accumulate in lysosomes of kidney and cultured cells and cause an impairment of phospholipid catabolism which is considered to be an early and significant step in the development of their toxicity. Using liposomes, wer previously demonstrated that the activity of lysosomal phospholipases A1 and A2 towards phosphatidylcholine was markedly enhanced by the inclusion of phosphatidylinositol in the bilayer, and that gentamicin impaired this activity by binding to phosphatidylinositol. Since gentamicin-induced inhibition was inversely related to the amount of phosphatidylinositol included in the liposomes, we proposed that gentamicin impairs activity of phospholipases by decreasing the quantity of available negative charges carried by the bilayer surface (Mingeot-Leclercq et al., Biochem Pharmacol 37: 591-599, 1988). We now extend these observations to phosphatidylserine and phosphatidic acid, and compare the inhibition caused by gentamicin, amikacin and streptomycin towards lysosomal phospholipases on the hydrolysis of phosphatidylcholine in the presence of each of these acidic phospholipids. Inclusion of phosphatidic acid in liposomes, and, to a lesser extent, phosphatidylserine, caused a larger increase in phospholipases activity than phosphatidylinositol. In parallel, the three aminoglycosides tested were found less inhibitory towards phospholipases activity measured on phosphatidic acid-or phosphatidylserine-containing liposomes than was previously observed with phosphatidylinositol, even though equilibrium dialysis experiments failed to demonstrate significant difference in binding parameters of the drug towards each of these liposomes populations. Yet, as for phosphatidylinositol-containing liposomes, the inhibition was inversely related to the amount of phosphatidic acid or phosphatidylserine included in the bilayer and the inhibitory potency of the three drugs was consistently gentamicin greater than amikacin greater than streptomycin with the three types of negatively-charged liposomes used. We conclude that impairment of lysosomal phospholipases activity towards phosphatidylcholine included in negatively-charged membranes by aminoglycoside antibiotics is dependent upon drug binding to the bilayer, but that it is modulated by the nature of the acidic phospholipid that binds the drug as well as by that of the drug itself. A companion paper (Mingeot-Leclercq et al., Biochem Pharmacol 40: 499-506, 1990) will examine by computer-aided conformational analysis the parameters (drug-phospholipid energy of interaction, position of the drug in a monolayer and its accessibility to the aqueous phase) which may be important for these effects.
氨基糖苷类抗生素积聚在肾脏和培养细胞的溶酶体中,并导致磷脂分解代谢受损,这被认为是其毒性发展过程中一个早期且重要的步骤。我们之前利用脂质体证明,双层膜中加入磷脂酰肌醇可显著增强溶酶体磷脂酶A1和A2对磷脂酰胆碱的活性,而庆大霉素通过与磷脂酰肌醇结合损害了这种活性。由于庆大霉素诱导的抑制作用与脂质体中所含磷脂酰肌醇的量呈负相关,我们提出庆大霉素通过减少双层膜表面可利用的负电荷数量来损害磷脂酶的活性(Mingeot-Leclercq等人,《生物化学与药物学》37: 591 - 599, 1988)。我们现在将这些观察结果扩展到磷脂酰丝氨酸和磷脂酸,并比较庆大霉素、阿米卡星和链霉素在这些酸性磷脂存在下对溶酶体磷脂酶水解磷脂酰胆碱的抑制作用。脂质体中加入磷脂酸以及在较小程度上加入磷脂酰丝氨酸,比加入磷脂酰肌醇能使磷脂酶活性有更大的增加。同时,发现所测试的三种氨基糖苷类抗生素对含磷脂酸或含磷脂酰丝氨酸的脂质体上测得的磷脂酶活性的抑制作用,比之前在含磷脂酰肌醇的脂质体上观察到的要小,尽管平衡透析实验未能证明药物对这些脂质体群体的结合参数有显著差异。然而,对于含磷脂酰肌醇的脂质体,抑制作用与双层膜中所含磷脂酸或磷脂酰丝氨酸的量呈负相关,并且在所使用的三种带负电荷的脂质体类型中,三种药物的抑制效力始终是庆大霉素大于阿米卡星大于链霉素。我们得出结论,氨基糖苷类抗生素对带负电荷膜中所含磷脂酰胆碱的溶酶体磷脂酶活性的损害取决于药物与双层膜的结合,但它受到结合药物的酸性磷脂的性质以及药物本身性质的调节。一篇配套论文(Mingeot-Leclercq等人,《生物化学与药物学》40: 499 - 506, 1990)将通过计算机辅助构象分析研究可能对这些效应重要的参数(药物 - 磷脂相互作用能、药物在单层中的位置及其与水相的可及性)。